Clinical Trials Browser

INDUSTRY × Lymphoma, Large B-Cell, Diffuse × tremelimumab × Clear all

NCT02549651 2019-02-27

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse

NCT02205333 2017-06-28

MEDI6469

Phase 1/2 Terminated

48 enrolled 28 charts

Lymphoma, Large B-Cell, Diffuse